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a b s t r a c t
Since its ﬁrst publication in 2003, the World Health Organization's “Safe abortion: technical and policy guidance
for health systems” has had an inﬂuence on abortion policy, law, and practice worldwide. To reﬂect signiﬁcant
developments in the clinical, service delivery, and human rights aspects of abortion care, the Guidance was
updated in 2012. This article reviews select recommendations of the updated Guidance, highlighting 3 key
themes that run throughout its chapters: evidence-based practice and assessment, human rights standards,
and a pragmatic orientation to safe and accessible abortion care. These themes not only connect the chapters
into a coherent whole. They reﬂect the research and advocacy efforts of a growing ﬁeld in women's health and
human rights.
© 2012 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

1. Introduction
In June 2012, the World Health Organization (WHO) issued an
update of its “Safe abortion: technical and policy guidance for health
systems” [1]. First published in 2003, the Guidance was the only
publication of its kind, offering global recommendations on clinical,
service-delivery, as well as legal and policy aspects, of safe abortion.
Since then, having been translated into French, Russian, and Spanish
among other languages, the Guidance has been used as a tool in strategic assessments conducted by ministries of health in 12 countries
including Mongolia [2], Macedonia [3], and Malawi [4], and in other
national efforts to improve the quality of and access to abortion care.
In 2006, for example, following the liberalization of the abortion law
in Colombia, the Guidance served as a template for national technical
norms on legal abortion services [5]. When the 2006 norms were subsequently challenged as unlawful and suspended, the Guidance was
proposed as a stopgap measure to ensure continuity of care.
Since the ﬁrst edition, there have been signiﬁcant developments in
the clinical, service delivery, and human rights aspects of safe abortion. The substantial revisions in the updated Guidance reﬂect these
changes, particularly in methods of abortion, decentralization and
expansion of service delivery, and in application of human rights in
policy making and legislative reform.
This article seeks to elaborate 3 key themes that unite these changes
across the Guidance. These themes are: afﬁrming an evidence-based
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approach, strengthening human rights standards, and reﬂecting a pragmatic orientation to safe and accessible abortion care.
First, the Guidance reﬂects an increasing emphasis that policy, law,
and practice should be based on the best available evidence, accounting
for the characteristics, needs, and preferences of the women seeking
care. Recommended interventions are those shown to have a positive
impact on health outcomes, including reduced abortion-related morbidity and mortality. The Guidance also cautions against barriers that
impede access to safe abortion care without evidence of health beneﬁt
or other justiﬁcation.
Second, the Guidance is ﬁrmly grounded in international human
rights treaties, and references a growing body of human rights standards on safe abortion. These standards are authoritative interpretations and applications of human rights in the context of abortion by
international and regional human rights bodies and national courts,
including the United Nations treaty monitoring bodies. The Guidance
cites examples of human rights standards on maternal mortality due
to unsafe abortion, the decriminalization of abortion, and the elimination of regulatory and administrative barriers that impede women's
access to lawful services [1] (Box 4.1, p.88–89).
Third, the Guidance follows the aphorism, “Let not the best be the
enemy of the good.” It recognizes that safe abortions, if inaccessible,
do little to redress the problem of unsafe abortion. The Guidance thus
sensibly calibrates accessibility and quality of care as co-determinants
of safe abortion. It pragmatically acknowledges that a single gold standard of abortion care is unrealistic in a guidance of global reach, and
so offers recommendations responsive to different settings, including
low-resource. Consider recommendations on medical methods of
abortion. The Guidance notes that the most effective regimens rely
on a combination of mifepristone and misoprostol [1] (p.42), but
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offers recommendations for misoprostol-alone regimens where mifepristone is unavailable [1] (pp.45–46).
These themes are elaborated below by reference to select recommendations in the clinical, service-delivery, and legal and policy chapters of the updated Guidance. These recommendations are intended to
be merely exemplary. The Guidance offers many more recommendations critical to ensuring safe and accessible abortion care.
2. Clinical care for women undergoing abortion
Chapter 2 addresses the clinical management of abortion, and is
accompanied by a companion document: “Clinical practice handbook
for safe abortion care” [6].
The clinical recommendations reﬂect a strong emphasis on
evidence-based medicine [7], but not to the exclusion of human rights
considerations. Rather, the Guidance shows how these approaches can
reinforce one another. Consider the strong recommendation against
dilation and sharp curettage (D&C), referred to as an “obsolete method
of surgical abortion” that “should be replaced by vacuum aspiration”
[1] (p.31). This recommendation is based on evidence of relative
safety [8]. It is also informed, however, by evidence that D&C is considerably more painful for women, and thus by considerations of improving not only safety but also quality of care [1] (p.41). Attention
to the experience of abortion, and especially to protecting against
unnecessary pain or needless discomfort, respects the human rights
of women, especially as set against an historic and in some places
current punitive practice of denying women anesthesia during care
[9]. To this end, the Guidance recommends “pain management…
should always be offered, and provided without delay to women
who desire it” [1] (p.39).
While Chapter 2 does not expressly cite human rights standards,
many of its clinical recommendations reﬂect them. Consider recommendations on pre-abortion information and counseling. Free and
informed decision making is recognized to be an essential part of
good quality abortion care. Chapter 2 states that “[i]nformation
must be provided to each woman…in a way that she can understand,
to allow her to make her own decisions about whether to have
an abortion and…by what method”, and that “[m]any women have
made a decision to have an abortion before seeking care, and this
decision should be respected without subjecting a woman to mandatory counseling” [1] (p.36). Chapter 4 links these recommendations to
human rights standards of access to information, respect for dignity,
and sensitivity to a woman's needs and perspectives [1] (p.97).
Women have a right to be fully informed of their options for health
care, such that the Guidance reminds states of their human rights
obligations to refrain from and to protect against censorship, withholding, or intentional misrepresentation of information about abortion services. Recommendations on contraceptive information and
counseling, as well as the initiation of contraception in the context of
abortion care, likewise reﬂect not only evidence-based standards, but
the human rights standard of freedom from coercion [1] (p.18), by
noting that “[a] woman's acceptance of a contraceptive method must
never be a precondition for providing her with an abortion” [1] (p.37).
That the updated Guidance does not set upper gestational limits
on safe abortion methods is an important change. The 2003 Guidance
summarized methods of abortion most appropriate at different stages
of pregnancy, ending the summary at 22 weeks gestation [10]. This
was misinterpreted to wrongly suggest that a safe abortion could
not be provided beyond 22 weeks, and that gestational prohibitions
were thereby justiﬁed on grounds of safety. The updated Guidance,
in contrast, states only that the “most appropriate methods of abortion differ by the duration of pregnancy” [1] (p.37) and offers recommendations for pregnancies beyond 24 weeks [1] (pp.115–116).
While safety is affected by the gestational age at the time of the abortion [11], the expansion of ﬁrst trimester services can never eliminate
the need for safe abortion later in pregnancy [12]. The reasons why
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women present for abortion at later gestations are many, including
service delivery barriers that delay care [13]. Women entitled to
a legal abortion should have access to the procedure as soon as possible, but ensuring access to safe and legal abortion later in pregnancy
is also critical to the health and lives of women, especially the
most vulnerable women, the poorest and the youngest, disproportionately represented among late seekers [14]. The Guidance thus
describes gestational prohibitions as a barrier to care that create social
inequities [1] (p.93).
3. Planning and managing safe abortion care
Chapter 3 addresses the service delivery context with the primary
recommendation that “safe abortion services should be readily available and affordable to all women” [1] (p.8). The chapter focuses on
factors necessary not only for clinical safety, but to ensure that all
women can access the safe abortion care to which they are legally entitled. Good quality and equitable access are dual objectives of health
system regulation [1] (p.65).
Reﬂecting this orientation, the Guidance emphasizes the simplifying, or streamlining of abortion care, even noting a high value on
research to demedicalize abortion care [1] (p.2). Chapter 3 speciﬁcally identiﬁes policies and practices that restrict women's access
without justiﬁcation. It stresses in equal measure what is not necessary, what is not required, to ensure safe abortion care, as much as
what is required. A historical perspective shows the importance of
such guidance. For too long the provision of and access to abortion
care was, and remains in many places today, burdened by regulation
that reﬂects not evidence-based practice, but ideological opposition.
These regulatory barriers, however, are often justiﬁed in the name
of health protection, but rarely with any evidence of health-related
need or beneﬁt. In the USA, the apronym, TRAP, short for the
“targeted regulation of abortion providers (and facilities),” suggests
the specious intention of such regulation [15]. The Guidance counsels that “certiﬁcation and licensing of services should be the same
as for other medical procedures and should not be a barrier to the
availability and provision of abortion care…[Regulation] should not
impose excessive requirements for infrastructure, equipment, or
staff that are not essential to the provision of safe services” [1] (p.67).
Rather the regulation of abortion services “should be evidence-based
to protect against over-medicalized, arbitrary or otherwise unreasonable requirements…regulation should be based on criteria required
for provision of safe abortion care” [1] (p.96).
Consider requirements for introducing medical methods of abortion into health systems, an integration that should be expanding
with mifepristone and misoprostol now on the WHO Model List of Essential Medicines [16]. Both vacuum aspiration and medical abortion,
the Guidance explains, “can be provided at the primary-care level on
an outpatient basis and do not require advanced technical knowledge
or skills, expensive equipment such as ultrasound, or a full complement of hospital staff (e.g. an anaesthesiologist)” [1] (p.67). Primarylevel delivery is “safe, and minimizes costs while maximizing the
convenience and timeliness of care for women” [1] (p.65), given
that most of the equipment, medications, and supplies needed
for both methods are the same as those needed for other gynecological services [1] (p.71).
That medical abortion can be provided at the primary-care level
should not be read, however, as a requirement that it must. Early in
2011, a UK legal challenge to allow for home use of misoprostol failed,
but the High Court ruled that the Department of Health could amend
the rules for service delivery if advances in medicine justiﬁed it [17].
The Guidance afﬁrms that home use of misoprostol is a safe option
for women [1] (p.44), and further acknowledges that “[a]llowing
home use of misoprostol following provision of mifepristone at a
health-care facility can further improve the privacy, convenience and
acceptability of services, without compromising on safety” [1] (p.65).
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The Guidance even suggests the evaluation of internet provision and
telemedicine, as further alternative service delivery channels of safe
abortion, as a subject for future research [1] (p.105).
To facilitate access to care, the Guidance also emphasizes differentiation in regulation to reﬂect different requirements for safe abortion
among different methods, facilities, and providers [1] (p.67). A key
example is competency-based training in the licensing of providers
[1] (p.63). This term implies that providers must only be trained
to the level of competence required for the tasks they undertake.
Competency-based training asks: What knowledge and skills are
required to safely provide this abortion method? To the extent that
abortion methods differ in the knowledge and skills required for
their safe provision, the Guidance envisions the training and thus
licensing of a range of healthcare providers to safely administer and
supervise abortion care, including midlevel (i.e. non-physician) providers [1] (pp.65,72). The support for midlevel providers is evidencebased. The Guidance cites comparative studies showing no difference
in complication rates between ﬁrst-trimester abortions provided by
midlevel providers and physicians [18]. More importantly, however,
support for midlevel providers reﬂects the reality that in many contexts,
making safe, legal abortion services accessible to all women depends
upon them.
The Guidance is not indifferent to the ends that service delivery
regulation serves. It does not merely require that policies and practices directed to whatever end be evidence-based. It identiﬁes explicitly an end result to which laws and services should be directed: the
protection and promotion of the health and human rights of women.
The Guidance overall reﬂects a renewed focus on women as more
than users of services or patients of health providers. Women are
treated as rights bearers within the health system, entitled not merely
to access safe and legal abortion services, but to do so “in a way that
respects a woman's dignity, guarantees her right to privacy and is
sensitive to her needs and perspectives” [1] (p.64). Privacy protections, for example, a private place to undress, curtained windows,
and cloth or paper draping during procedures, are guaranteed not
merely because their absence may deter women from seeking
care, but in respect of a woman's right to privacy, to ensure her
comfort and ease [1] (p.69). Reﬂecting the same approach, the
Guidance recognizes that “[r]espect for a woman's choice among
different safe and effective methods of abortion is an important
value in health-service delivery” [1] (p.67). In this way, health systems are regarded as “not only producers of health or health care
but…purveyors of a wider set of societal values and norms” [19].
The Guidance seeks to imbue the delivery of abortion services with
values of respect, worth, and dignity. “Abortion services should be
integrated into the health system…to acknowledge their status as
legitimate health services and to protect against stigmatization and
discrimination of women and health-care providers” [1] (p.64).
4. Legal and policy considerations
Chapter 4 addresses legal and policy considerations, and “highlights
the inextricable link between women's health and human rights and
the need for laws and policies that promote and protect both” [1]
(p.87). It uses both evidence-based and human rights standards to
recommend signiﬁcant change in the regulation of abortion.
The Guidance favors an evidence-based assessment of abortion
laws, that is, it looks to the evidence of the actual rather than
intended effect of the law. It ﬁnds that legal restrictions on abortion
do not result in fewer abortions, nor do laws that facilitate access
increase the rate or numbers of abortion [1] (p.90). Whether abortion
is legally restricted or not, the likelihood that a woman will have
an abortion remains the same [1] (p.23). Legal status does make a
difference, however, to the safety of abortion. The Guidance cites
overwhelming evidence of association between legal restrictions and
higher numbers of unsafe abortions and related mortality. In contrast,

where safe abortion services are legally available on broad social
grounds or on a woman's request, the incidence of and mortality
from unsafe abortion can be reduced to a minimum [1] (p.90).
This evidence-based rationale for legal reform is complemented
by human rights standards that recommend the decriminalization
of medical services needed only by women [1] (p.89), and minimum
legal grounds for abortion, including threats to the pregnant woman's
life or health, and where pregnancy results from rape or incest [1]
(p.92). The Guidance thus no longer starts from the baseline that “in
circumstances where abortion is not against the law” such abortion
must be safe and accessible. It recognizes that the law itself may require reform as a matter of evidence-based policy and human rights
obligations [1] (p.88).
The Guidance further acknowledges that human rights standards
apply not only to the enactment of legal grounds, but also to their
interpretation. Women are often wrongly denied services to which
they are lawfully entitled because service providers and facility administrators interpret legal grounds in an unduly restrictive manner
[20]. The Guidance thus provides important recommendations on
the broad scope of legal grounds. It advises, for example, that where
laws permit abortion to protect health, this permission can extend
to the full WHO constitutional description of health: “a state of
complete physical, mental and social well-being.” Grounds for fetal
impairment or rape, where not explicit in the law, may likewise
constitute a threat to the woman's health by reference to the mental
distress they may cause [1] (p.92). The Guidance not only sets forth
broad interpretations, it also elaborates human rights obligations
on governments to establish “[i]nstitutional and administrative
mechanisms…[to] protect against unduly restrictive interpretations
of legal grounds” [1] (p.98). In this respect, the Guidance follows
a growing body of human rights jurisprudence on accountability
in the administration of legal grounds, recognizing the rights of
women to participate in the decision-making process, and to the
timely appeal and review of denials of legal care [21].
Health system and service delivery barriers are also often codiﬁed
in law and regulation, which signiﬁcantly restrict access and are thus
also subject to evidence-based assessment and human rights standards. These barriers include restrictions on access to information,
the over-regulation of facilities, providers, and methods of abortion,
and the under-regulation of privacy and the exercise of conscience
objection, among others [1] (p.94).
A human rights rationale for eliminating these legal and regulatory barriers often resides in their impeding women's access to safe
abortion care. Evidence-based assessment shows the many ways
these barriers deter, delay, and increase the costs for women seeking
care [1] (p.94). These barriers violate human rights because they
jeopardize women's access to safe, legal abortion care, and therefore
jeopardize women's health. The Guidance notes, for example, that
health providers' exercise of conscientious objection without any
enforced requirement of referral to a willing and trained provider, can
delay if not deny care for women in need of safe abortion, increasing
risks to their health and lives [1] (p.96).
The strong human rights orientation of the Guidance can, however,
perhaps best be seen in its attention to service delivery regulation
that violates women's human rights for reason more than jeopardy
to health. The Guidance, for example, recognizes that third-party
authorization requirements, including hospital approval committees
and police reporting, violate human rights of equality and nondiscrimination not simply because they deter and delay access, but because they do so disproportionately for vulnerable and marginalized
women [1] (p.95). Safe abortions “become the privilege of the rich,
while poor women have little choice but to resort to unsafe providers”
[1] (p.1). The injustice of such regulation is not simply denied access,
but inequitable access. Third-party authorization further violates
human rights by interfering with “women's and adolescents' right to
make decisions about reproduction and to exercise control over their
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bodies” [1] (p.89). Like mandatory counseling policies and waiting
periods, authorization requirements demean women as competent
decision makers [1] (p.96).
5. Conclusion
The interwoven themes of evidence-based practice and assessment, human rights standards, and a pragmatic orientation to safe
and accessible care not only unite the various parts of the Guidance
into a coherent whole. They reﬂect the profound nature of change
in this ﬁeld. The Guidance is the product of an extensive review of
voluminous new research on the epidemiological, clinical, service
delivery, legal, and human rights aspects of abortion, and of meaningful engagement with a diverse set of global stakeholders, including
health service providers, health program managers, researchers,
methodologists, human rights lawyers, and women's health advocates. The Guidance, in other words, has beneﬁtted enormously
from the dedicated efforts of a growing ﬁeld in women's health and
human rights. The task now is to turn knowledge into practice, for
the Guidance to guide, and to effect real change in women's access
to safe abortion.
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